- Top health expert says US is sliding backwards on handling of pandemic
- Amy McGrath wins over Charles Booker in Kentucky primary
- Reports: ‘Russian bounties’ intelligence was in Trump daily briefing
- EU bans travelers from US
- Sign up to our First Thing newsletter
The US has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against Covid-19, leaving none for the UK, Europe or most of the rest of the world.
Experts and access to medicines campaigners are alarmed both by the US unilateral action on remdesivir and the wider implications, for instance in the event of a vaccine becoming available. The Trump administration has already shown it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.
US intelligence picked up transfers of large sums from Russian military intelligence to Taliban-linked bank accounts, the New York Times reports, shoring up its reporting on a suspected Russian bounty offer in 2019 for attacks on coalition forces in Afghanistan.
Donald Trump has cast doubt on whether such a Russian program existed, and the White House has said US intelligence was inconclusive.
This is yet another example of the Trump administration lies about classified information causing additional leaks. https://t.co/iwilLb19eL